REQUEST A DEMO
Total
USD $0.00
Search more companies

Marek Bachanski Neuronek sp. k. (Poland)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Lessors of Real Estate | Administrative Management and General Management Consulting Services | Office Administrative Services | All Other Miscellaneous Schools and Instruction | All Other Miscellaneous Ambulatory Health Care Services | General Medical and Surgical Hospitals
Full name: Marek Bachanski Neuronek sp. k. Profile Updated: May 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Marek Bachanski Neuronek sp. k. is a company in Poland, with a head office in Warsaw. It operates in the Ambulatory Health Care Services sector. It was incorporated on November 25, 2020. The latest financial highlights indicate a net sales revenue drop of 6.85% in 2023. During that time, Marek Bachanski Neuronek sp. k.’s total assets grew by 6.88%. The net profit margin of Marek Bachanski Neuronek sp. k. decreased by 8.99% in 2023.

Headquarters
Ul. Kwatery Glownej 46B/U4
Warsaw; Mazowieckie; Postal Code: 04-294

Contact Details: Purchase the Marek Bachanski Neuronek sp. k. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Marek Bachanski Neuronek sp. k. report to view the information.
Incorporation Date:
November 25, 2020
Key Executives
Purchase this report to view the information.
Associate Partner
Purchase this report to view the information.
Limited Partner
Company Performance
Financial values in the chart are available after Marek Bachanski Neuronek sp. k. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-6.85%
Total operating revenue
-6.51%
Operating profit (EBIT)
-23.11%
Net Profit (Loss) for the Period
-23.03%
Total assets
6.88%
Total equity
-18.36%
Operating Profit Margin (ROS)
-9.94%
Net Profit Margin
-8.99%
Return on Equity (ROE)
-4.56%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?